• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于脓毒症管理的纳米平台:快速检测/预警、病原体清除及恢复免疫稳态

Nanoplatforms for Sepsis Management: Rapid Detection/Warning, Pathogen Elimination and Restoring Immune Homeostasis.

作者信息

Luo Gan, Zhang Jue, Sun Yaqi, Wang Ya, Wang Hanbin, Cheng Baoli, Shu Qiang, Fang Xiangming

机构信息

Department of Anesthesiology and Intensive Care, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003 People's Republic of China.

National Clinical Research Center for Child Health, Children's Hospital, School of Medicine, Zhejiang University, Hangzhou, 310052 People's Republic of China.

出版信息

Nanomicro Lett. 2021 Mar 8;13:88. doi: 10.1007/s40820-021-00598-3. eCollection 2021 Dec.

DOI:10.1007/s40820-021-00598-3
PMID:33717630
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7938387/
Abstract

Sepsis, a highly life-threatening organ dysfunction caused by uncontrollable immune responses to infection, is a leading contributor to mortality in intensive care units. Sepsis-related deaths have been reported to account for 19.7% of all global deaths. However, no effective and specific therapeutic for clinical sepsis management is available due to the complex pathogenesis. Concurrently eliminating infections and restoring immune homeostasis are regarded as the core strategies to manage sepsis. Sophisticated nanoplatforms guided by supramolecular and medicinal chemistry, targeting infection and/or imbalanced immune responses, have emerged as potent tools to combat sepsis by supporting more accurate diagnosis and precision treatment. Nanoplatforms can overcome the barriers faced by clinical strategies, including delayed diagnosis, drug resistance and incapacity to manage immune disorders. Here, we present a comprehensive review highlighting the pathogenetic characteristics of sepsis and future therapeutic concepts, summarizing the progress of these well-designed nanoplatforms in sepsis management and discussing the ongoing challenges and perspectives regarding future potential therapies. Based on these state-of-the-art studies, this review will advance multidisciplinary collaboration and drive clinical translation to remedy sepsis.

摘要

脓毒症是由对感染的失控免疫反应引起的一种高度危及生命的器官功能障碍,是重症监护病房死亡的主要原因。据报道,脓毒症相关死亡占全球所有死亡人数的19.7%。然而,由于发病机制复杂,目前尚无有效的临床脓毒症治疗方法。同时消除感染和恢复免疫稳态被视为脓毒症治疗的核心策略。由超分子和药物化学引导的先进纳米平台,针对感染和/或免疫反应失衡,已成为通过支持更准确的诊断和精准治疗来对抗脓毒症的有力工具。纳米平台可以克服临床策略面临的障碍,包括诊断延迟、耐药性和无法管理免疫紊乱。在此,我们进行全面综述,强调脓毒症的发病特征和未来治疗理念,总结这些精心设计的纳米平台在脓毒症治疗方面的进展,并讨论未来潜在治疗方法面临的挑战和前景。基于这些前沿研究,本综述将推动多学科合作并促进临床转化以治疗脓毒症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/756e868f396a/40820_2021_598_Fig20_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/1cb9971ead1a/40820_2021_598_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/37dca437ba17/40820_2021_598_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/d4247b96a94f/40820_2021_598_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/be1127a94e26/40820_2021_598_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/fa62c09eee54/40820_2021_598_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/8e2b94997a6e/40820_2021_598_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/ab4d7698e6c4/40820_2021_598_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/4c1d1b1a6f11/40820_2021_598_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/cfe50d2c4173/40820_2021_598_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/35a24a532c92/40820_2021_598_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/e2e31a927259/40820_2021_598_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/416ed297162b/40820_2021_598_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/d45a4c3bd20b/40820_2021_598_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/35c771167021/40820_2021_598_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/7c40c5efedcd/40820_2021_598_Fig15_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/e4bbd8ce898d/40820_2021_598_Fig16_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/6e551f55bbbe/40820_2021_598_Fig17_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/c42467b88b6f/40820_2021_598_Fig18_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/f86cc18d4888/40820_2021_598_Fig19_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/756e868f396a/40820_2021_598_Fig20_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/1cb9971ead1a/40820_2021_598_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/37dca437ba17/40820_2021_598_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/d4247b96a94f/40820_2021_598_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/be1127a94e26/40820_2021_598_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/fa62c09eee54/40820_2021_598_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/8e2b94997a6e/40820_2021_598_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/ab4d7698e6c4/40820_2021_598_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/4c1d1b1a6f11/40820_2021_598_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/cfe50d2c4173/40820_2021_598_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/35a24a532c92/40820_2021_598_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/e2e31a927259/40820_2021_598_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/416ed297162b/40820_2021_598_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/d45a4c3bd20b/40820_2021_598_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/35c771167021/40820_2021_598_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/7c40c5efedcd/40820_2021_598_Fig15_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/e4bbd8ce898d/40820_2021_598_Fig16_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/6e551f55bbbe/40820_2021_598_Fig17_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/c42467b88b6f/40820_2021_598_Fig18_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/f86cc18d4888/40820_2021_598_Fig19_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492e/8006500/756e868f396a/40820_2021_598_Fig20_HTML.jpg

相似文献

1
Nanoplatforms for Sepsis Management: Rapid Detection/Warning, Pathogen Elimination and Restoring Immune Homeostasis.用于脓毒症管理的纳米平台:快速检测/预警、病原体清除及恢复免疫稳态
Nanomicro Lett. 2021 Mar 8;13:88. doi: 10.1007/s40820-021-00598-3. eCollection 2021 Dec.
2
Sepsis Care Pathway 2019.2019年脓毒症护理路径
Qatar Med J. 2019 Nov 7;2019(2):4. doi: 10.5339/qmj.2019.qccc.4. eCollection 2019.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
5
Recent advancements of nanomaterial-based therapeutic strategies toward sepsis: bacterial eradication, anti-inflammation, and immunomodulation.基于纳米材料的治疗策略在败血症方面的最新进展:细菌清除、抗炎和免疫调节。
Nanoscale. 2021 Jun 24;13(24):10726-10747. doi: 10.1039/d1nr02706a.
6
Recent Advances in Immunomodulatory Therapy in Sepsis: A Comprehensive Review.脓毒症免疫调节治疗的最新进展:全面综述
Cureus. 2024 Mar 31;16(3):e57309. doi: 10.7759/cureus.57309. eCollection 2024 Mar.
7
Developments and Trends of Nanotechnology Application in Sepsis: A Comprehensive Review Based on Knowledge Visualization Analysis.纳米技术在脓毒症应用中的发展和趋势:基于知识可视化分析的综合述评。
ACS Nano. 2024 Mar 19;18(11):7711-7738. doi: 10.1021/acsnano.3c10458. Epub 2024 Mar 1.
8
Immune dysregulation in sepsis: experiences, lessons and perspectives.脓毒症中的免疫失调:经验、教训与展望。
Cell Death Discov. 2023 Dec 19;9(1):465. doi: 10.1038/s41420-023-01766-7.
9
Pathophysiology of sepsis-induced cardiomyopathy.脓毒症性心肌病的病理生理学。
Nat Rev Cardiol. 2021 Jun;18(6):424-434. doi: 10.1038/s41569-020-00492-2. Epub 2021 Jan 20.
10
Advancing cell-based therapy in sepsis: An anesthesia outlook.推进脓毒症的细胞治疗:麻醉学展望。
Chin Med J (Engl). 2024 Jul 5;137(13):1522-1534. doi: 10.1097/CM9.0000000000003097. Epub 2024 May 6.

引用本文的文献

1
Nanocarrier-Based Targeting of Pattern Recognition Receptors as an Innovative Strategy for Enhancing Sepsis Therapy.基于纳米载体靶向模式识别受体作为增强脓毒症治疗的创新策略
Adv Healthc Mater. 2025 Sep;14(23):e2501146. doi: 10.1002/adhm.202501146. Epub 2025 Jul 2.
2
Evaluating the influence MRSA Co-infection on 28-day mortality among sepsis patients: insights from the MIMIC-IV database.评估耐甲氧西林金黄色葡萄球菌(MRSA)合并感染对脓毒症患者28天死亡率的影响:来自多中心重症医学信息库-Ⅳ(MIMIC-IV)数据库的见解
Front Pharmacol. 2025 Mar 11;16:1534107. doi: 10.3389/fphar.2025.1534107. eCollection 2025.
3
The existing evidence for the use of extracellular vesicles in the treatment of osteoporosis: a review.

本文引用的文献

1
Gold Nanozymes: From Concept to Biomedical Applications.金纳米酶:从概念到生物医学应用
Nanomicro Lett. 2020 Oct 27;13(1):10. doi: 10.1007/s40820-020-00532-z.
2
Cell Membrane Coating Technology: A Promising Strategy for Biomedical Applications.细胞膜包被技术:生物医学应用的一种有前景的策略。
Nanomicro Lett. 2019 Nov 16;11(1):100. doi: 10.1007/s40820-019-0330-9.
3
Long-term antibacterial composite via alginate aerogel sustained release of antibiotics and Cu used for bone tissue bacteria infection.长效抗菌复合水凝胶通过海藻酸钙气凝胶持续释放抗生素和 Cu 用于骨组织细菌感染。
细胞外囊泡用于治疗骨质疏松症的现有证据:一项综述
Int J Surg. 2025 May 1;111(5):3414-3429. doi: 10.1097/JS9.0000000000002339.
4
Paving the Way for NLRP3 Inflammasome Inactivation Using ADAM10 and Alpha-Hemolysin: An Investigation.利用ADAM10和α-溶血素为NLRP3炎性小体失活铺平道路:一项研究。
ACS Omega. 2025 Feb 17;10(8):7981-7988. doi: 10.1021/acsomega.4c09015. eCollection 2025 Mar 4.
5
A Cross-talk between Nanomedicines and Cardiac Complications: Comprehensive View.纳米药物与心脏并发症之间的相互作用:综合视角
Curr Pharm Des. 2025;31(10):741-752. doi: 10.2174/0113816128347223241021111914.
6
From nature to nanomedicine: bioengineered metallic nanoparticles bridge the gap for medical applications.从天然物质到纳米医学:生物工程金属纳米颗粒为医学应用架起桥梁。
Discov Nano. 2024 May 9;19(1):85. doi: 10.1186/s11671-024-04021-9.
7
Zn-Shik-PEG nanoparticles alleviate inflammation and multi-organ damage in sepsis.Zn-Shik-PEG 纳米颗粒减轻脓毒症中的炎症和多器官损伤。
J Nanobiotechnology. 2023 Nov 25;21(1):448. doi: 10.1186/s12951-023-02224-3.
8
Bacteriostatic Effects of Yujin Powder and Its Components on Clinical Isolation of Multidrug-Resistant Avian Pathogenic .郁金散及其成分对多重耐药禽致病性临床分离株的抑菌作用
Vet Sci. 2023 May 4;10(5):328. doi: 10.3390/vetsci10050328.
9
Nanomaterials targeting macrophages in sepsis: A promising approach for sepsis management.纳米材料靶向脓毒症中的巨噬细胞:脓毒症管理的一种有前途的方法。
Front Immunol. 2022 Dec 9;13:1026173. doi: 10.3389/fimmu.2022.1026173. eCollection 2022.
10
Multiple datasets to explore the molecular mechanism of sepsis.利用多个数据集探索脓毒症的分子机制。
BMC Genom Data. 2022 Aug 15;23(1):66. doi: 10.1186/s12863-022-01078-2.
Int J Biol Macromol. 2021 Jan 15;167:1211-1220. doi: 10.1016/j.ijbiomac.2020.11.075. Epub 2020 Nov 13.
4
Evaluation of VCAM-1 Targeted Naringenin/Indocyanine Green-Loaded Lipid Nanoemulsions as Theranostic Nanoplatforms in Inflammation.评估靶向血管细胞黏附分子-1的柚皮素/吲哚菁绿负载脂质纳米乳剂作为炎症诊断治疗纳米平台的性能
Pharmaceutics. 2020 Nov 9;12(11):1066. doi: 10.3390/pharmaceutics12111066.
5
Antibacterial Action of Nanoparticles by Lethal Stretching of Bacterial Cell Membranes.纳米颗粒通过致死性拉伸细菌细胞膜发挥抗菌作用。
Adv Mater. 2020 Dec;32(52):e2005679. doi: 10.1002/adma.202005679. Epub 2020 Nov 12.
6
A Reactive Oxygen Species Scavenging and O Generating Injectable Hydrogel for Myocardial Infarction Treatment In vivo.一种用于体内心肌梗死治疗的活性氧清除和产氧可注射水凝胶。
Small. 2020 Dec;16(48):e2005038. doi: 10.1002/smll.202005038. Epub 2020 Nov 9.
7
Co-Delivery of Hispolon and Doxorubicin Liposomes Improves Efficacy Against Melanoma Cells.载 Hispolon 和多柔比星脂质体提高了对黑素瘤细胞的疗效。
AAPS PharmSciTech. 2020 Nov 4;21(8):304. doi: 10.1208/s12249-020-01846-2.
8
Chitosan-based nanoparticles against bacterial infections.壳聚糖纳米粒子对抗细菌感染。
Carbohydr Polym. 2021 Jan 1;251:117108. doi: 10.1016/j.carbpol.2020.117108. Epub 2020 Sep 20.
9
Third-Generation Cephalosporin-Loaded Chitosan Used to Limit Microorganisms Resistance.负载第三代头孢菌素的壳聚糖用于限制微生物耐药性。
Materials (Basel). 2020 Oct 27;13(21):4792. doi: 10.3390/ma13214792.
10
Multimodal Mesoporous Silica Nanocarriers for Dual Stimuli-Responsive Drug Release and Excellent Photothermal Ablation of Cancer Cells.多模态介孔硅纳米载体用于双重刺激响应药物释放和优异的癌细胞光热消融。
Int J Nanomedicine. 2020 Oct 8;15:7667-7685. doi: 10.2147/IJN.S254344. eCollection 2020.